Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 563

1.
2.

Bacille Calmette-Guérin vaccination for the prevention of tuberculosis in health care workers.

Brewer TF, Colditz GA.

Clin Infect Dis. 1995 Jan;20(1):136-42. Review.

PMID:
7727639
3.

The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.

Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, Burdick E, Fineberg HV.

Pediatrics. 1995 Jul;96(1 Pt 1):29-35.

PMID:
7596718
4.

Correlation between BCG genomics and protective efficacy.

Behr MA.

Scand J Infect Dis. 2001;33(4):249-52. Review.

PMID:
11345214
5.

Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.

Flaherty DK, Vesosky B, Beamer GL, Stromberg P, Turner J.

J Leukoc Biol. 2006 Dec;80(6):1262-71. Epub 2006 Sep 12.

PMID:
16968819
7.

Recent developments in tuberculosis vaccines.

Haile M, Källenius G.

Curr Opin Infect Dis. 2005 Jun;18(3):211-5. Review.

PMID:
15864097
8.

Applying experiences from trials of bacille Calmette-Guérin vaccine.

Wilson ME.

Clin Infect Dis. 2000 Jun;30 Suppl 3:S262-5. Review.

PMID:
10875796
9.

Mapping the global use of different BCG vaccine strains.

Ritz N, Curtis N.

Tuberculosis (Edinb). 2009 Jul;89(4):248-51. doi: 10.1016/j.tube.2009.03.002. Epub 2009 Jun 18.

PMID:
19540166
10.

Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis.

Wedlock DN, Denis M, Vordermeier HM, Hewinson RG, Buddle BM.

Vet Immunol Immunopathol. 2007 Jul 15;118(1-2):50-8. Epub 2007 Apr 19.

PMID:
17524495
11.

[Recent progress in mycobacteriology].

Okada M, Kobayashi K.

Kekkaku. 2007 Oct;82(10):783-99. Japanese.

PMID:
18018602
12.

Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine.

Comstock GW.

Clin Infect Dis. 2000 Jun;30 Suppl 3:S250-3. Review.

PMID:
10875793
13.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
14.

Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.

Edwards ML, Goodrich JM, Muller D, Pollack A, Ziegler JE, Smith DW.

J Infect Dis. 1982 May;145(5):733-41.

PMID:
6804577
15.

The lack of relationship between serum content of MBL, sCD14, anti-PPD and anti-Hsp65 IgG and ingestion of Mycobacterium bovis BCG bacilli by phagocytes.

Paziak-Domańska B, Bonar A, Kowalewicz-Kulbat M, Klink M, Kowalski M, Karhukorpi J, Karttunen R, Jurkiewicz M, Rózalska B, Rudnicka W.

Arch Immunol Ther Exp (Warsz). 2002;50(5):337-44.

PMID:
12455868
16.

Auxotrophic vaccines for tuberculosis.

Guleria I, Teitelbaum R, McAdam RA, Kalpana G, Jacobs WR Jr, Bloom BR.

Nat Med. 1996 Mar;2(3):334-7.

PMID:
8612234
17.

Bacille Calmette-Guérin vaccines: a rough guide.

Fine PE.

Clin Infect Dis. 1995 Jan;20(1):11-4. No abstract available.

PMID:
7727635
18.

Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?

Moliva JI, Turner J, Torrelles JB.

Vaccine. 2015 Sep 22;33(39):5035-41. doi: 10.1016/j.vaccine.2015.08.033. Epub 2015 Aug 28. Review.

19.

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Oettinger T, Jørgensen M, Ladefoged A, Hasløv K, Andersen P.

Tuber Lung Dis. 1999;79(4):243-50. Review.

PMID:
10692993
20.

A double-blind, placebo-controlled study of Mycobacterium-specific human immune responses induced by intradermal bacille Calmette-Guérin vaccination.

Hoft DF, Kemp EB, Marinaro M, Cruz O, Kiyono H, McGhee JR, Belisle JT, Milligan TW, Miller JP, Belshe RB.

J Lab Clin Med. 1999 Sep;134(3):244-52.

PMID:
10482309

Supplemental Content

Support Center